Real-time Estimate
Cboe BZX
10:20:02 2024-06-28 EDT
|
5-day change
|
1st Jan Change
|
1.795
USD
|
+2.57%
|
|
+5.00%
|
-7.99%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,333
|
1,408
|
363.3
|
123.8
|
113.6
|
-
|
-
|
Enterprise Value (EV)
1 |
2,901
|
1,007
|
-57.92
|
-192.4
|
-156.2
|
-119
|
-89.11
|
P/E ratio
|
-22.6
x
|
-19.5
x
|
-3.89
x
|
-1.44
x
|
-1.33
x
|
-1.23
x
|
-1.42
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
5,081
x
|
213
x
|
23.5
x
|
7.43
x
|
6.77
x
|
4.83
x
|
3.23
x
|
EV / Revenue
|
4,422
x
|
152
x
|
-3.74
x
|
-11.5
x
|
-9.3
x
|
-5.05
x
|
-2.54
x
|
EV / EBITDA
|
-90.5
x
|
-14.6
x
|
0.62
x
|
1.97
x
|
1.76
x
|
1.37
x
|
1.19
x
|
EV / FCF
|
-114
x
|
-18.9
x
|
0.82
x
|
2.9
x
|
3.19
x
|
1.63
x
|
1.78
x
|
FCF Yield
|
-0.87%
|
-5.29%
|
123%
|
34.5%
|
31.4%
|
61.4%
|
56.1%
|
Price to Book
|
7.71
x
|
2.81
x
|
0.82
x
|
0.29
x
|
0.32
x
|
0.36
x
|
0.41
x
|
Nbr of stocks (in thousands)
|
59,366
|
61,708
|
62,642
|
63,825
|
64,937
|
-
|
-
|
Reference price
2 |
56.14
|
22.81
|
5.800
|
1.940
|
1.750
|
1.750
|
1.750
|
Announcement Date
|
3/29/21
|
2/28/22
|
3/2/23
|
2/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
0.656
|
6.617
|
15.49
|
16.66
|
16.79
|
23.53
|
35.15
|
EBITDA
1 |
-32.04
|
-68.92
|
-93.29
|
-97.88
|
-88.59
|
-87.06
|
-74.74
|
EBIT
1 |
-33.65
|
-71.47
|
-97.24
|
-103.5
|
-95.36
|
-93.39
|
-81.39
|
Operating Margin
|
-5,129.42%
|
-1,080.14%
|
-627.61%
|
-620.99%
|
-567.95%
|
-396.85%
|
-231.55%
|
Earnings before Tax (EBT)
1 |
-32.78
|
-71.17
|
-92.97
|
-86.28
|
-84.75
|
-92.2
|
-80
|
Net income
1 |
-32.78
|
-71.17
|
-92.97
|
-86.28
|
-84.9
|
-92.2
|
-80.51
|
Net margin
|
-4,996.19%
|
-1,075.55%
|
-600.05%
|
-517.84%
|
-505.66%
|
-391.79%
|
-229.05%
|
EPS
2 |
-2.480
|
-1.170
|
-1.490
|
-1.350
|
-1.313
|
-1.417
|
-1.237
|
Free Cash Flow
1 |
-25.36
|
-53.27
|
-71.04
|
-66.37
|
-49
|
-73
|
-50
|
FCF margin
|
-3,866.16%
|
-805.03%
|
-458.56%
|
-398.38%
|
-291.84%
|
-310.19%
|
-142.26%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/29/21
|
2/28/22
|
3/2/23
|
2/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
3.066
|
3.312
|
3.621
|
3.955
|
4.604
|
4.053
|
4.008
|
4.162
|
4.438
|
3.066
|
3.2
|
4.75
|
5.8
|
4.25
|
5.1
|
EBITDA
1 |
-19.04
|
-22.91
|
-22.53
|
-24
|
-23.85
|
-26.2
|
-26.64
|
-24.4
|
-20.65
|
-23.7
|
-23.85
|
-21.1
|
-19.65
|
-22.9
|
-25.6
|
EBIT
1 |
-19.87
|
-23.79
|
-23.43
|
-25.07
|
-24.95
|
-27.44
|
-27.94
|
-25.84
|
-22.23
|
-25.19
|
-25.55
|
-22.8
|
-21.35
|
-24.3
|
-26.9
|
Operating Margin
|
-648.21%
|
-718.18%
|
-647.17%
|
-633.78%
|
-541.94%
|
-677.15%
|
-697.13%
|
-620.98%
|
-500.95%
|
-821.66%
|
-798.44%
|
-480%
|
-368.1%
|
-571.76%
|
-527.45%
|
Earnings before Tax (EBT)
1 |
-19.74
|
-23.65
|
-22.82
|
-23.98
|
-22.53
|
-23.96
|
-23.43
|
-21.09
|
-17.8
|
-20.68
|
-23.5
|
-20.9
|
-19.55
|
-21.3
|
-23.8
|
Net income
1 |
-19.74
|
-23.65
|
-22.82
|
-23.98
|
-22.53
|
-23.96
|
-23.43
|
-21.09
|
-17.8
|
-20.68
|
-23.5
|
-20.9
|
-19.55
|
-21.3
|
-23.8
|
Net margin
|
-643.8%
|
-713.95%
|
-630.07%
|
-606.32%
|
-489.27%
|
-591.14%
|
-584.61%
|
-506.68%
|
-401.06%
|
-674.46%
|
-734.38%
|
-440%
|
-337.07%
|
-501.18%
|
-466.67%
|
EPS
2 |
-0.3200
|
-0.3800
|
-0.3700
|
-0.3800
|
-0.3600
|
-0.3800
|
-0.3700
|
-0.3300
|
-0.2800
|
-0.3200
|
-0.3656
|
-0.3267
|
-0.3053
|
-0.3300
|
-0.3700
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/28/22
|
5/4/22
|
8/9/22
|
11/8/22
|
3/2/23
|
5/9/23
|
8/8/23
|
11/7/23
|
2/29/24
|
5/8/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
432
|
400
|
421
|
316
|
270
|
233
|
203
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-25.4
|
-53.3
|
-71
|
-66.4
|
-49
|
-73
|
-50
|
ROE (net income / shareholders' equity)
|
-12.6%
|
-15.2%
|
-19.6%
|
-20.4%
|
-21.8%
|
-25.8%
|
-25%
|
ROA (Net income/ Total Assets)
|
-12.2%
|
-14.5%
|
-18.1%
|
-18.7%
|
-20.5%
|
-27.4%
|
-23.9%
|
Assets
1 |
267.8
|
490.7
|
513.5
|
462.1
|
414.9
|
336.7
|
336.8
|
Book Value Per Share
2 |
7.280
|
8.110
|
7.050
|
6.590
|
5.430
|
4.810
|
4.230
|
Cash Flow per Share
|
-1.580
|
-0.7600
|
-0.9700
|
-
|
-
|
-
|
-
|
Capex
1 |
4.53
|
6.92
|
10.3
|
7.31
|
4
|
2
|
2
|
Capex / Sales
|
691.16%
|
104.61%
|
66.26%
|
43.87%
|
23.82%
|
8.5%
|
5.69%
|
Announcement Date
|
3/29/21
|
2/28/22
|
3/2/23
|
2/29/24
|
-
|
-
|
-
|
Last Close Price
1.75
USD Average target price
7
USD Spread / Average Target +300.00% Consensus |
1st Jan change
|
Capi.
|
---|
| -7.99% | 114M | | -11.88% | 4.33B | | +1.07% | 3.15B | | +17.42% | 2.22B | | +10.85% | 1.07B | | +7.84% | 936M | | -38.92% | 928M | | -56.62% | 684M | | -29.11% | 629M | | -37.22% | 614M |
Scientific & Precision Equipment
|